The Deal

JULY 20, 2023

As the Securities and Exchange Commission reopens the comment period on proposed rules to increase transparency in the derivatives market, industry experts are questioning data put forward by the agency on the draft regulation’s impact on activist investors. NRG), worth about $1 billion, that’s likely in derivatives.

Funds 52

Funds Investors Shares Investment 52

Focus Investment Banking

AUGUST 6, 2023

ESG isn’t just a matter for large, publicly traded companies. While many people see this as merely “doing the right thing,” there is also often an economic payoff. This is particularly true if your partners are publicly traded or foreign-owned. It’s increasingly becoming a must for small and medium-sized businesses.

Middle Market 52

Middle Market Business Government Profitability 52

Intrepid Banker Insights

MARCH 28, 2023

Intrepid Investment Bankers Warning Signs Your Business’s Liquidity Needs Attention Mixed signals dominate economic headlines as concerns persist about a recession beginning in 2023, if it has not already begun. At the same time, employment remains strong, with the unemployment rate hitting an all-time low.

Capital 52

Capital Advisory Bank Banking 52

Cooley M&A

MARCH 1, 2019

These include prevailing market sentiment, current appetite for acquisitions in a particular sector and the political and economic environment, all of which can change well within a given transaction timetable. The usual pros and cons of being a publicly traded company will also need to be considered.

IPO 52

IPO Valuation M&A Business 52

Software Equity Group

MARCH 13, 2023

While median EV/Revenue multiples declined from 4Q20–1Q22, they still outperformed the median public market multiple, and SaaS M&A deal volume jumped to a new record. Despite the macroeconomic uncertainty, buyers and investors are still willing to pay a premium for mission-critical, recession-resistant companies.

M&A 52

M&A Private Equity Equities S&P 52

Software Equity Group

FEBRUARY 28, 2023

Public SaaS companies enjoyed an unprecedented run from 2009 through 2021, but last year brought a wave of macroeconomic uncertainty, including rising interest rates, record inflation, supply chain problems, and geopolitical unrest. What is the SEG Index? Companies exceeding 80% surpassed the Index median by 22%.

Valuation 52

Valuation M&A Stock Profitability 52

Focus Investment Banking

JUNE 13, 2023

Yet, if anything, PE involvement in “low-competition environments such as outpatient oncology” has trailed that in other medical fields, such as dermatology and gastroenterology, which have become “crowded” with PE investors, said Krishna Patel, a consultant at Sojus LLC, which provides strategic marketing content for biopharmaceutical companies.

Hospitality 52

Hospitality Private Equity Mergers and Acquisitions Medical 52

Wall Street Mojo

FEBRUARY 9, 2024

A primary importance of it is helping investors identify companies with high growth potential along with the risks involved. The classification helps investors gauge the performance and growth potential to make future investments. Such firms enjoy high growth rates and play a vital economic role.

Middle Market 52

Middle Market Bulge Bracket Private Equity Investment Banking 52

The TRADE

JULY 11, 2023

In the current market and economic climate most asset managers aren’t keen to try out that message in the short-term, but it’s definitely possible that the situation could evolve as we move through the cycle.”

Asset Management 40

Asset Management Investment Government Capital Market 40

Software Equity Group

OCTOBER 22, 2024

In today’s economic climate, retention is everything: Software companies with Net Revenue Retention (NRR) rates above 120% are trading at a remarkable 63% premium over the market median. In this article, we will explore NRR in depth, examining its role in public software companies and sharing takeaways for leaders and executives.

Valuation 52

Valuation Investors IT Management 52

Cooley M&A

SEPTEMBER 16, 2022

In addition, currently public dual-class companies with transfer provisions that do not contain clear carve outs for the delivery of voting agreements in the M&A context should discuss with their advisers the possibility of adopting “clear day” amendments to their charters to include these carve outs. Vote-down termination fee (i.e.,

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Cooley M&A

JANUARY 25, 2023

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. Novartis announced plans to spin off its generics and biosimilars division into a publicly traded stand-alone company.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Mergers and Inquisitions

DECEMBER 4, 2024

No matter the economic climate, you can always bet on sports fans to show up for their favorite teams. However, one common point across all the verticals is that IPOs are not common because there aren’t that many publicly traded sports teams, stadiums, or arenas.

Investment Banking 105

Investment Banking Banking Bank Investment 105

Cooley M&A

JANUARY 20, 2022

For example, early in 2021, Zimmer Biomet Holdings announced that it would spin off its spine and dental businesses into a new publicly traded company as a way to “optimize resource allocation” among its remaining businesses. There is a history of drugs failing for one use and then being successfully developed for other uses.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Focus Investment Banking

DECEMBER 20, 2024

to a strategic buyer confirms the value retina practices hold for healthcare investors and operators. Cencora, one of the largest publicly-traded pharmaceutical companies in the world, distributes pharmaceuticals, over-the-counter healthcare products and other healthcare supplies and equipment to healthcare providers.

Private Equity 52

Private Equity Healthcare Equities Sale 52

Cooley M&A

JANUARY 22, 2025

Looking ahead, expect the fruits of these efforts to free up valuable resources capital and management bandwidth that can be redirected toward higher-value, strategic acquisitions in 2025 as the general economic backdrop (inflation, interest rates, antitrust) looks to become more conducive to bigger bets.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64